NOTCH2 and triple-negative breast carcinoma: Importantly, next-generation sequencing identified high frequency rearrangements of Notch1 and Notch2 in triple negative breast cancer (6 of 66 tumors), which leading to constitute receptor activation; interestingly, cell lines with this genetic changes were sensitive to GSI treatment by in vitro and in vivo assays [49].